Golden State Equity Partners Viatris Inc Transaction History
Golden State Equity Partners
- $182 Million
- Q3 2024
A detailed history of Golden State Equity Partners transactions in Viatris Inc stock. As of the latest transaction made, Golden State Equity Partners holds 13 shares of VTRS stock, worth $172. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13Holding current value
$172% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding VTRS
# of Institutions
1,102Shares Held
934MCall Options Held
2.71MPut Options Held
2.4M-
Vanguard Group Inc Valley Forge, PA141MShares$1.87 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.23 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$836 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$830 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$646 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $16.1B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...